The integration of Artificial Intelligence (AI) into the medical science field represents a pivotal moment in healthcare, offering a pathway either toward unprecedented growth and innovation or toward challenges marked by job displacement and economic uncertainties. This juncture requires a thoughtful navigation of AI’s capabilities to amplify the collective potential of the healthcare sector without
Read more
In a landmark deal within the Indian pharmaceutical sector, ERIS Lifesciences has acquired the India-branded formulations business of Biocon Biologics for Rs. 1242 Crore ($150 million), equivalent to 3.4 times the revenue. This acquisition marks ERIS Lifesciences’ entry into the burgeoning $3.6 billion injectables market in India, signifying a pivotal move in its business strategy.
Read more
The Indian pharmaceutical industry, often hailed as the “Pharmacy of the World,” stands at a crossroads marked by commendable achievements and significant challenges. This industry has been pivotal in manufacturing and supplying affordable generic drugs globally, contributing to healthcare accessibility and affordability. However, a deeper look into its practices reveals a landscape marred by regulatory
Read more
In their invited commentary for the American Head and Neck Society, published in the JAMA Otolaryngology Head Neck Surg journal on July 9, 2023, Dr. Evan M. Graboyes and Dr. Sue S. Yom delve into the critical issues surrounding treatment delays in oral cavity cancer, emphasizing the significant impacts these delays have on patient outcomes.
Read more
Most Commented